UniProt ID | 1433Z_HUMAN | |
---|---|---|
UniProt AC | P63104 | |
Protein Name | 14-3-3 protein zeta/delta | |
Gene Name | YWHAZ | |
Organism | Homo sapiens (Human). | |
Sequence Length | 245 | |
Subcellular Localization | Cytoplasm . Melanosome . Located to stage I to stage IV melanosomes. | |
Protein Description | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.. | |
Protein Sequence | MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDKNELVQ -------CCHHHHHH | 17.45 | 22814378 | |
3 | Methylation | -----MDKNELVQKA -----CCHHHHHHHH | 51.53 | 19608861 | |
3 | Malonylation | -----MDKNELVQKA -----CCHHHHHHHH | 51.53 | 26320211 | |
3 | Ubiquitination | -----MDKNELVQKA -----CCHHHHHHHH | 51.53 | 19608861 | |
3 | Acetylation | -----MDKNELVQKA -----CCHHHHHHHH | 51.53 | 19608861 | |
9 | Acetylation | DKNELVQKAKLAEQA CHHHHHHHHHHHHHH | 39.75 | 25953088 | |
9 | Ubiquitination | DKNELVQKAKLAEQA CHHHHHHHHHHHHHH | 39.75 | 21890473 | |
9 | Malonylation | DKNELVQKAKLAEQA CHHHHHHHHHHHHHH | 39.75 | 26320211 | |
11 | Acetylation | NELVQKAKLAEQAER HHHHHHHHHHHHHHH | 56.09 | 72611865 | |
11 | Ubiquitination | NELVQKAKLAEQAER HHHHHHHHHHHHHHH | 56.09 | 21906983 | |
19 | Phosphorylation | LAEQAERYDDMAACM HHHHHHHHHHHHHHH | 14.06 | 76971701 | |
25 | S-nitrosocysteine | RYDDMAACMKSVTEQ HHHHHHHHHHHHHHH | 2.27 | - | |
25 | S-nitrosylation | RYDDMAACMKSVTEQ HHHHHHHHHHHHHHH | 2.27 | 25040305 | |
27 | Ubiquitination | DDMAACMKSVTEQGA HHHHHHHHHHHHHHH | 41.48 | - | |
27 | Acetylation | DDMAACMKSVTEQGA HHHHHHHHHHHHHHH | 41.48 | 25953088 | |
28 | Phosphorylation | DMAACMKSVTEQGAE HHHHHHHHHHHHHHH | 13.85 | 25849741 | |
30 | Phosphorylation | AACMKSVTEQGAELS HHHHHHHHHHHHHCC | 29.67 | 23090842 | |
37 | Phosphorylation | TEQGAELSNEERNLL HHHHHHCCHHHHHHH | 33.43 | 29978859 | |
45 | Phosphorylation | NEERNLLSVAYKNVV HHHHHHHHHHHHHHH | 14.10 | 19664994 | |
47 | Ubiquitination | ERNLLSVAYKNVVGA HHHHHHHHHHHHHCC | 13.25 | 21890473 | |
48 | Phosphorylation | RNLLSVAYKNVVGAR HHHHHHHHHHHHCCC | 10.84 | 22617229 | |
49 | Malonylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 26320211 | |
49 | Methylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 19608861 | |
49 | Acetylation | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 19608861 | |
49 | Ubiquitination | NLLSVAYKNVVGARR HHHHHHHHHHHCCCC | 33.26 | 21906983 | |
57 | Phosphorylation | NVVGARRSSWRVVSS HHHCCCCCCHHHHHH | 28.79 | 23882029 | |
58 | Phosphorylation | VVGARRSSWRVVSSI HHCCCCCCHHHHHHH | 19.65 | 15883165 | |
63 | Phosphorylation | RSSWRVVSSIEQKTE CCCHHHHHHHHHHCC | 23.81 | 26657352 | |
64 | Phosphorylation | SSWRVVSSIEQKTEG CCHHHHHHHHHHCCH | 20.66 | 29255136 | |
68 | Ubiquitination | VVSSIEQKTEGAEKK HHHHHHHHCCHHHHH | 35.44 | 21906983 | |
68 | Malonylation | VVSSIEQKTEGAEKK HHHHHHHHCCHHHHH | 35.44 | 26320211 | |
68 | Acetylation | VVSSIEQKTEGAEKK HHHHHHHHCCHHHHH | 35.44 | 19608861 | |
69 | Phosphorylation | VSSIEQKTEGAEKKQ HHHHHHHCCHHHHHH | 39.07 | 23312004 | |
74 | Acetylation | QKTEGAEKKQQMARE HHCCHHHHHHHHHHH | 56.18 | 7851853 | |
74 | Ubiquitination | QKTEGAEKKQQMARE HHCCHHHHHHHHHHH | 56.18 | - | |
75 | Acetylation | KTEGAEKKQQMAREY HCCHHHHHHHHHHHH | 36.95 | 11924237 | |
75 | Ubiquitination | KTEGAEKKQQMAREY HCCHHHHHHHHHHHH | 36.95 | - | |
82 | Phosphorylation | KQQMAREYREKIETE HHHHHHHHHHHHHHH | 20.65 | 75027 | |
85 | Ubiquitination | MAREYREKIETELRD HHHHHHHHHHHHHHH | 36.52 | - | |
85 | Acetylation | MAREYREKIETELRD HHHHHHHHHHHHHHH | 36.52 | 23749302 | |
85 | Methylation | MAREYREKIETELRD HHHHHHHHHHHHHHH | 36.52 | - | |
88 | Phosphorylation | EYREKIETELRDICN HHHHHHHHHHHHHHH | 43.74 | 101661999 | |
94 | S-palmitoylation | ETELRDICNDVLSLL HHHHHHHHHHHHHHH | 4.10 | 26865113 | |
94 | Glutathionylation | ETELRDICNDVLSLL HHHHHHHHHHHHHHH | 4.10 | 22555962 | |
94 | S-nitrosylation | ETELRDICNDVLSLL HHHHHHHHHHHHHHH | 4.10 | 19483679 | |
94 | S-nitrosocysteine | ETELRDICNDVLSLL HHHHHHHHHHHHHHH | 4.10 | - | |
99 | Phosphorylation | DICNDVLSLLEKFLI HHHHHHHHHHHHHCC | 30.65 | 28450419 | |
103 | Ubiquitination | DVLSLLEKFLIPNAS HHHHHHHHHCCCCHH | 45.50 | - | |
110 | Phosphorylation | KFLIPNASQAESKVF HHCCCCHHHCCHHEE | 36.24 | 29255136 | |
114 | Phosphorylation | PNASQAESKVFYLKM CCHHHCCHHEEEEEE | 36.82 | 29255136 | |
115 | Succinylation | NASQAESKVFYLKMK CHHHCCHHEEEEEEC | 28.06 | 23954790 | |
115 | Acetylation | NASQAESKVFYLKMK CHHHCCHHEEEEEEC | 28.06 | 23954790 | |
115 | Ubiquitination | NASQAESKVFYLKMK CHHHCCHHEEEEEEC | 28.06 | 21890473 | |
120 | Acetylation | ESKVFYLKMKGDYYR CHHEEEEEECCHHHH | 27.47 | 19608861 | |
120 | Ubiquitination | ESKVFYLKMKGDYYR CHHEEEEEECCHHHH | 27.47 | 21906983 | |
122 | Ubiquitination | KVFYLKMKGDYYRYL HEEEEEECCHHHHHH | 47.22 | 21906983 | |
125 | Phosphorylation | YLKMKGDYYRYLAEV EEEECCHHHHHHHHH | 9.86 | 28152594 | |
126 | Phosphorylation | LKMKGDYYRYLAEVA EEECCHHHHHHHHHH | 9.49 | 28152594 | |
128 | Phosphorylation | MKGDYYRYLAEVAAG ECCHHHHHHHHHHCC | 8.31 | 28102081 | |
138 | Acetylation | EVAAGDDKKGIVDQS HHHCCCCCCCCCCHH | 58.60 | 23749302 | |
138 | Ubiquitination | EVAAGDDKKGIVDQS HHHCCCCCCCCCCHH | 58.60 | 21906983 | |
139 | Acetylation | VAAGDDKKGIVDQSQ HHCCCCCCCCCCHHH | 61.95 | 70527 | |
139 | Malonylation | VAAGDDKKGIVDQSQ HHCCCCCCCCCCHHH | 61.95 | 26320211 | |
139 | Ubiquitination | VAAGDDKKGIVDQSQ HHCCCCCCCCCCHHH | 61.95 | 21890473 | |
145 | Phosphorylation | KKGIVDQSQQAYQEA CCCCCCHHHHHHHHH | 21.57 | 28152594 | |
149 | Phosphorylation | VDQSQQAYQEAFEIS CCHHHHHHHHHHHHH | 11.53 | 20560217 | |
156 | Phosphorylation | YQEAFEISKKEMQPT HHHHHHHHHHHCCCC | 30.40 | 28152594 | |
157 | Malonylation | QEAFEISKKEMQPTH HHHHHHHHHHCCCCC | 59.42 | 26320211 | |
157 | Acetylation | QEAFEISKKEMQPTH HHHHHHHHHHCCCCC | 59.42 | 25953088 | |
157 | Ubiquitination | QEAFEISKKEMQPTH HHHHHHHHHHCCCCC | 59.42 | - | |
158 | Ubiquitination | EAFEISKKEMQPTHP HHHHHHHHHCCCCCC | 52.18 | 21906983 | |
160 | Sulfoxidation | FEISKKEMQPTHPIR HHHHHHHCCCCCCCC | 8.75 | 28183972 | |
178 | Phosphorylation | ALNFSVFYYEILNSP EEEHHHHHHHHHCCH | 9.68 | - | |
184 | Phosphorylation | FYYEILNSPEKACSL HHHHHHCCHHHHHHH | 30.87 | 20058876 | |
184 | O-linked_Glycosylation | FYYEILNSPEKACSL HHHHHHCCHHHHHHH | 30.87 | 23301498 | |
189 | S-nitrosocysteine | LNSPEKACSLAKTAF HCCHHHHHHHHHHHH | 5.19 | - | |
189 | S-nitrosylation | LNSPEKACSLAKTAF HCCHHHHHHHHHHHH | 5.19 | 19483679 | |
190 | Phosphorylation | NSPEKACSLAKTAFD CCHHHHHHHHHHHHH | 35.90 | 24719451 | |
193 | Ubiquitination | EKACSLAKTAFDEAI HHHHHHHHHHHHHHH | 45.75 | 21906983 | |
194 | Phosphorylation | KACSLAKTAFDEAIA HHHHHHHHHHHHHHH | 27.27 | 28464451 | |
205 | Phosphorylation | EAIAELDTLSEESYK HHHHHHHCCCHHHCC | 44.82 | 29255136 | |
207 | Phosphorylation | IAELDTLSEESYKDS HHHHHCCCHHHCCCH | 41.22 | 19664994 | |
210 | Phosphorylation | LDTLSEESYKDSTLI HHCCCHHHCCCHHHH | 33.17 | 29255136 | |
211 | Phosphorylation | DTLSEESYKDSTLIM HCCCHHHCCCHHHHH | 23.30 | 28176443 | |
212 | "N6,N6-dimethyllysine" | TLSEESYKDSTLIMQ CCCHHHCCCHHHHHH | 55.25 | - | |
212 | Methylation | TLSEESYKDSTLIMQ CCCHHHCCCHHHHHH | 55.25 | - | |
214 | Phosphorylation | SEESYKDSTLIMQLL CHHHCCCHHHHHHHH | 22.44 | 28450419 | |
215 | Phosphorylation | EESYKDSTLIMQLLR HHHCCCHHHHHHHHH | 30.36 | 29255136 | |
226 | Phosphorylation | QLLRDNLTLWTSDTQ HHHHHCCEEEECCCC | 26.89 | 22167270 | |
229 | Phosphorylation | RDNLTLWTSDTQGDE HHCCEEEECCCCCCC | 21.60 | 30266825 | |
230 | Phosphorylation | DNLTLWTSDTQGDEA HCCEEEECCCCCCCC | 27.38 | 30266825 | |
232 | Phosphorylation | LTLWTSDTQGDEAEA CEEEECCCCCCCCCC | 33.93 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
58 | S | Phosphorylation | Kinase | AKT1 | P31749 | Uniprot |
58 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
58 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
58 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
58 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
58 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
58 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
58 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
184 | S | Phosphorylation | Kinase | MK08 | P45983 | PhosphoELM |
232 | T | Phosphorylation | Kinase | BCR | P11274 | PSP |
232 | T | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
232 | T | Phosphorylation | Kinase | CK1 | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 1433Z_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-210, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3; LYS-49; LYS-68; LYS-115AND LYS-120, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-210, AND MASS SPECTROMETRY. | |
"Protein kinase A phosphorylates and regulates dimerization of 14-3-3epsilon."; Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.; FEBS Lett. 580:305-310(2006). Cited for: PHOSPHORYLATION AT SER-58, DIMERIZATION, INTERACTION WITH TP53 ANDYWHAE, FUNCTION, AND MUTAGENESIS OF SER-58. | |
"JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting ofc-Abl in the apoptotic response to DNA damage."; Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.; Nat. Cell Biol. 7:278-285(2005). Cited for: INTERACTION WITH ABL1, MASS SPECTROMETRY, PHOSPHORYLATION AT SER-184,AND MUTAGENESIS OF SER-184. | |
"Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism."; Ma Y., Pitson S., Hercus T., Murphy J., Lopez A., Woodcock J.; J. Biol. Chem. 280:26011-26017(2005). Cited for: PHOSPHORYLATION AT SER-58, AND MUTAGENESIS OF SER-58. | |
"JNK promotes Bax translocation to mitochondria throughphosphorylation of 14-3-3 proteins."; Tsuruta F., Sunayama J., Mori Y., Hattori S., Shimizu S.,Tsujimoto Y., Yoshioka K., Masuyama N., Gotoh Y.; EMBO J. 23:1889-1899(2004). Cited for: PHOSPHORYLATION AT SER-184, INTERACTION WITH BAX, FUNCTION, ANDMUTAGENESIS OF SER-184. | |
"The dimeric versus monomeric status of 14-3-3zeta is controlled byphosphorylation of Ser58 at the dimer interface."; Woodcock J.M., Murphy J., Stomski F.C., Berndt M.C., Lopez A.F.; J. Biol. Chem. 278:36323-36327(2003). Cited for: PHOSPHORYLATION AT SER-58, AND DIMERIZATION. | |
"Identification of 14-3-3zeta as a protein kinase B/Akt substrate."; Powell D.W., Rane M.J., Chen Q., Singh S., McLeish K.R.; J. Biol. Chem. 277:21639-21642(2002). Cited for: PHOSPHORYLATION AT SER-58, AND INTERACTION WITH AKT1. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND MASSSPECTROMETRY. | |
"14-3-3 is phosphorylated by casein kinase I on residue 233.Phosphorylation at this site in vivo regulates Raf/14-3-3interaction."; Dubois T., Rommel C., Howell S., Steinhussen U., Soneji Y.,Morrice N., Moelling K., Aitken A.; J. Biol. Chem. 272:28882-28888(1997). Cited for: PHOSPHORYLATION AT THR-232, INTERACTION WITH RAF1, AND FUNCTION. |